Lacidipine
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C26H33NO6 |
Molar mass | 455.543 g/mol |
WikiDoc Resources for Lacidipine |
Articles |
---|
Most recent articles on Lacidipine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Lacidipine at Clinical Trials.gov Clinical Trials on Lacidipine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Lacidipine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Lacidipine Discussion groups on Lacidipine Patient Handouts on Lacidipine Directions to Hospitals Treating Lacidipine Risk calculators and risk factors for Lacidipine
|
Healthcare Provider Resources |
Causes & Risk Factors for Lacidipine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Lacidipine (tradenames Lacipil, Motens) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.
References
External links
- Motens 2 mg Summary of Product Characteristics
- Motens 4 mg Summary of Product Characteristics
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Cardiovascular Drugs
- Drug